@article{HBSN21952,
author = {Yasuyuki Shigematsu and Kentaro Inamura},
title = {Gut microbiome: A key player in cancer immunotherapy},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {7},
number = {6},
year = {2018},
keywords = {},
abstract = {Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic approaches used to treat cancer. Immune checkpoint molecules located on tumor cells interact with receptors on cytotoxic CD8+ T cells (a type of effector T lymphocyte) and consequently lead to evasion of tumor cells from the immune system.},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/21952}
}